Torchmark Corp. (TMK) Misses Q1 EPS by 1c; CEO Stepping Down
Tweet
Share
E-mailGet Alerts TMK Hot Sheet
Price: $88.10 --0%
Financial Fact:
Continuing operations: 1.19
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Continuing operations: 1.19
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Torchmark Corp. (NYSE: TMK) reported Q1 EPS of $1.27, $0.01 worse than the analyst estimate of $1.28.
Torchmark Corp. sees FY2012 EPS of $5.10-$5.40, versus the consensus of $5.27.
Effective June 1, 2012, Chairman and Chief Executive Officer Mark S. McAndrew, with 32 years of service to Torchmark, will step down as Chief Executive Officer. Mr. McAndrew will continue to serve in an executive capacity as Chairman of the Board of Directors.
The Torchmark Board of Directors has unanimously appointed Gary L. Coleman, currently Torchmark's Executive Vice President and Chief Financial Officer, and Larry M. Hutchison, currently Torchmark's Executive Vice President and General Counsel, as co-Chief Executive Officers, effective June 1, 2012.
For earnings history and earnings-related data on Torchmark Corp. (TMK) click here.
Torchmark Corp. sees FY2012 EPS of $5.10-$5.40, versus the consensus of $5.27.
Effective June 1, 2012, Chairman and Chief Executive Officer Mark S. McAndrew, with 32 years of service to Torchmark, will step down as Chief Executive Officer. Mr. McAndrew will continue to serve in an executive capacity as Chairman of the Board of Directors.
The Torchmark Board of Directors has unanimously appointed Gary L. Coleman, currently Torchmark's Executive Vice President and Chief Financial Officer, and Larry M. Hutchison, currently Torchmark's Executive Vice President and General Counsel, as co-Chief Executive Officers, effective June 1, 2012.
For earnings history and earnings-related data on Torchmark Corp. (TMK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Innovaro (INV) Misses Q2 EPS by 9c
- MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
Create E-mail Alert Related Categories
Earnings, Guidance, Management ChangesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
